News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
839,136 Results
Type
Article (86119)
Company Profile (649)
Press Release (752368)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232230)
Career Advice (4125)
Deals (39710)
Drug Delivery (126)
Drug Development (90799)
Employer Resources (198)
FDA (18002)
Job Trends (17325)
News (395577)
Policy (39676)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2992)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (80)
Alliances (56664)
ALS (80)
Alzheimer's disease (1471)
Antibody-drug conjugate (ADC) (143)
Approvals (17992)
Artificial intelligence (225)
Autoimmune disease (27)
Automation (12)
Bankruptcy (402)
Best Places to Work (12511)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (447)
Bladder cancer (76)
Brain cancer (26)
Breast cancer (231)
Cancer (2038)
Cardiovascular disease (141)
Career advice (3531)
Career pathing (34)
CAR-T (161)
Cell therapy (448)
Cervical cancer (17)
Clinical research (72839)
Collaboration (787)
Compensation (445)
Complete response letters (28)
COVID-19 (2831)
CRISPR (43)
C-suite (225)
Cystic fibrosis (99)
Data (1875)
Decentralized trials (2)
Denatured (45)
Depression (38)
Diabetes (187)
Diagnostics (6759)
Digital health (9)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (118)
Drug pricing (95)
Drug shortages (17)
Duchenne muscular dystrophy (82)
Earnings (95374)
Editorial (37)
Employer branding (25)
Employer resources (167)
Events (128554)
Executive appointments (619)
FDA (18953)
Featured Employer (63)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (648)
Gene editing (99)
Generative AI (22)
Gene therapy (318)
GLP-1 (736)
Government (5109)
Grass and pollen (4)
Guidances (38)
Healthcare (20744)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (129)
Indications (25)
Infectious disease (2946)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (43)
Intellectual property (86)
Interviews (812)
IPO (17691)
IRA (38)
Job creations (5186)
Job search strategy (2861)
Kidney cancer (11)
Labor market (41)
Layoffs (541)
Leadership (21)
Legal (10057)
Liver cancer (72)
Lung cancer (294)
Lymphoma (138)
Machine learning (6)
Management (65)
Manufacturing (291)
MASH (69)
Medical device (14300)
Medtech (14305)
Mergers & acquisitions (22283)
Metabolic disorders (596)
Multiple sclerosis (77)
NASH (22)
Neurodegenerative disease (102)
Neuropsychiatric disorders (23)
Neuroscience (1971)
NextGen: Class of 2025 (7666)
Non-profit (5058)
Northern California (2338)
Now hiring (40)
Obesity (319)
Opinion (271)
Ovarian cancer (69)
Pain (68)
Pancreatic cancer (63)
Parkinson's disease (133)
Partnered (19)
Patents (195)
Patient recruitment (93)
Peanut (48)
People (64907)
Pharmaceutical (131)
Pharmacy benefit managers (13)
Phase I (22508)
Phase II (31672)
Phase III (23805)
Pipeline (1031)
Policy (141)
Postmarket research (3542)
Preclinical (10148)
Press Release (72)
Prostate cancer (90)
Psychedelics (34)
Radiopharmaceuticals (252)
Rare diseases (361)
Real estate (7384)
Recruiting (75)
Regulatory (26441)
Reports (55)
Research institute (2647)
Resumes & cover letters (649)
Rett syndrome (2)
RNA editing (5)
RSV (34)
Schizophrenia (70)
Series A (125)
Series B (72)
Service/supplier (25)
Sickle cell disease (46)
Southern California (1994)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (34)
Startups (4285)
State (2)
Stomach cancer (11)
Supply chain (51)
Tariffs (37)
The Weekly (82)
United States (19982)
Vaccines (733)
Venture capitalists (41)
Weight loss (228)
Women's health (37)
Worklife (19)
Date
Today (130)
Last 7 days (707)
Last 30 days (2256)
Last 365 days (29080)
2025 (8782)
2024 (34032)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (54)
Alaska (6)
Arizona (245)
Arkansas (8)
Asia (49855)
Australia (8797)
California (5328)
Canada (1580)
China (498)
Colorado (167)
Connecticut (215)
Delaware (132)
Europe (114106)
Florida (666)
Georgia (145)
Hawaii (1)
Idaho (64)
Illinois (446)
India (25)
Indiana (270)
Iowa (10)
Japan (135)
Kansas (111)
Kentucky (16)
Louisiana (8)
Maine (58)
Maryland (840)
Massachusetts (4203)
Michigan (182)
Minnesota (310)
Mississippi (1)
Missouri (54)
Montana (24)
Nebraska (26)
Nevada (54)
New Hampshire (50)
New Jersey (1521)
New Mexico (27)
New York (1506)
North Carolina (1008)
North Dakota (8)
Northern California (2338)
Ohio (163)
Oklahoma (13)
Oregon (45)
Pennsylvania (1135)
Puerto Rico (12)
Rhode Island (24)
South America (1648)
South Carolina (4)
South Dakota (1)
Southern California (1994)
Tennessee (30)
Texas (700)
Utah (115)
Virginia (102)
Washington D.C. (39)
Washington State (515)
West Virginia (1)
Wisconsin (40)
839,136 Results for "bio techne".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES - May 31, 2024
Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor conferences.
May 31, 2024
·
1 min read
Business
Bio-Techne Releases Third Quarter Fiscal 2024 Results
Bio-Techne Corporation reported its financial results for the third quarter ending March 31, 2024.
May 1, 2024
·
23 min read
BioMidwest
Bio-Techne Declares Dividend - May 01, 2024
Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2024.
May 1, 2024
·
2 min read
Business
Bio-Techne Appoints Dr. Judith Klimovsky to Board of Directors
Bio-Techne Corporation announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company’s Board of Directors, April 24, 2024.
April 30, 2024
·
1 min read
Business
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
Bio-Techne Corporation is pleased to announce a significant milestone in its commitment to providing cutting-edge solutions to its customers.
April 29, 2024
·
4 min read
BioMidwest
BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
Bio-Techne Corporation today announced that Kim Kelderman, President and Chief Executive Officer will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024 , at 8:40 a.m. CDT.
May 23, 2024
·
1 min read
BioMidwest
Bio-Techne Surpasses 10,000 Peer-Reviewed Publications Citing RNAscope Technology
Bio-Techne Corporation announced that Advanced Cell Diagnostics, part of Bio-Techne’s Spatial Biology Division, has surpassed 10,000 peer-reviewed publications referencing the use and application of RNAscope™ ISH technology.
April 8, 2024
·
2 min read
BioMidwest
Bio-Techne to Highlight Multiple Applications of the MauriceFlex™ System at the Annual ASMS Conference
Bio-Techne Corporation will showcase multiple applications of its recently launched MauriceFlex™ System at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics, taking place June 2nd-6th in Anaheim, California.
May 30, 2024
·
3 min read
BioMidwest
Bio-Techne to Present at the BofA Securities Health Care Conference 2024
Bio-Techne Corporation announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities Health Care Conference on Tuesday, May 14, 2024, at 2:20 p.m. PDT.
May 8, 2024
·
1 min read
BioMidwest
Bio-Techne and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay
Bio-Techne Corporation and Novomol-Dx, a molecular diagnostics company, are pleased to announce the development of Bio-Marker Pathfinder, a first of its kind ocular biomarker kit, as a point-of-care application.
April 26, 2024
·
3 min read
1 of 83,914
Next
